Potential scenarios for the progression of a COVID-19 epidemic in the European Union and the European Economic Area, March 2020.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
03 2020
Historique:
entrez: 12 3 2020
pubmed: 12 3 2020
medline: 19 3 2020
Statut: ppublish

Résumé

Two months after the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the possibility of established and widespread community transmission in the European Union and European Economic Area (EU/EEA) is becoming more likely. We provide scenarios for use in preparedness for a possible widespread epidemic. The EU/EEA is moving towards the 'limited sustained transmission' phase. We propose actions to prepare for potential mitigation phases and coordinate efforts to protect the health of citizens.

Identifiants

pubmed: 32156332
doi: 10.2807/1560-7917.ES.2020.25.9.2000202
pmc: PMC7068161
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
Lancet. 2020 Feb 29;395(10225):689-697
pubmed: 32014114
Euro Surveill. 2020 Feb;25(6):
pubmed: 32046815

Auteurs

Helen C Johnson (HC)

European Centre for Disease Prevention and Control, Solna, Sweden.
These authors contributed equally.

Céline M Gossner (CM)

European Centre for Disease Prevention and Control, Solna, Sweden.
These authors contributed equally.

Edoardo Colzani (E)

European Centre for Disease Prevention and Control, Solna, Sweden.

John Kinsman (J)

European Centre for Disease Prevention and Control, Solna, Sweden.

Leonidas Alexakis (L)

European Centre for Disease Prevention and Control, Solna, Sweden.

Julien Beauté (J)

European Centre for Disease Prevention and Control, Solna, Sweden.

Andrea Würz (A)

European Centre for Disease Prevention and Control, Solna, Sweden.

Svetla Tsolova (S)

European Centre for Disease Prevention and Control, Solna, Sweden.

Nick Bundle (N)

European Centre for Disease Prevention and Control, Solna, Sweden.

Karl Ekdahl (K)

European Centre for Disease Prevention and Control, Solna, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH